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(p = <0.01 and 0.02 respectively). All of the mutations 259 were more common in males than females, although 260 this only reached statistical significance for GPR126 261 and LEPROTL1 (p = 0.018 and 0.033 respectively).
262
None of the mutations were strongly associated with 263 tobacco smoking, although GPR126, PLEKHS1 and 264 TBC1D12 mutation rates were significantly lower 265 in smokers than in ex-smokers or never smokers 266 (Table S3 ). GPR126 mutations were strongly associ-267 ated with increasing stage and grade of disease ( Fig.   268 S1), and were more frequent in larger and multifocal 269 tumours (Table S3) . wt UBCs but was significantly higher in grade 3 280 disease than grade 1 disease (p = 0.041) ( Fig. S2 ).
281
Genome wide analysis did not identify many differen- 2)).
294
The mutation frequency was 24% in group 1 (mostly 295 low grade pTa), 37% in group 3 (mostly high grade 296 NMIBC) and significantly higher (50%) in group 2
297
(high grade pT1 and MIBC) (p < 0.001). We also 298 utilised RNAseq data to investigate if non-coding 299 mutations in any of the genes influence gene isoform 300 expression; however, none of the mutations had an 301 influence ( Fig. 3 and S3 ). (p = 0.06) and NMIBC patients (p = 0.05).
351

DISCUSSION
352
We have studied non-coding mutations at 5 sites 
